The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis
Abstract
Aim: Drug‐induced liver injury (DILI) is becoming a worldwide problem with its still unexplained properties. Methods: The data of patients who were diagnosed with DILI between January 2008 and December 2013 were assessed. Results: Five patients had been diagnosed with intrinsic and 82 patients with idiosyncratic DILI. The most common causative agents were antimicrobial drugs. The most common injury pattern was hepatocellular. When patients with bilirubin levels of more than 5 mg/dL were divided into two groups according to receiving steroid therapy (n = 11) or not (n = 40), there was not any significant difference according to their clinical results (P > 0.05). Five of the idiosyncratic DILI patients were diagnosed with drug‐induced autoimmune hepatitis (DI‐AIH). In histopathological examination, hepatic rosette formation and emperipolesis were observed to be more common among patients with DI‐AIH when compared with ones without (P < 0.05). Interestingly, in the remaining patients with DILI (n = 77), three of them were diagnosed with classic autoimmune hepatitis during long‐term follow up (range, 11–51 months). Conclusion: The most common causes were antimicrobials, but any agents that have not been defined to cause DILI can induce DILI. The efficacy of steroids in DILI has not been observed but all deaths were observed in the steroid‐free group. The association of DILI and AIH was observed in two different types in terms of diagnosis in our study. The first association was DI‐AIH. The second one is the classical AIH which developed in three patients after a few months following spontaneous recovery of DILI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recovery time was reported to be longer for DI-ALH than for DILI (8-10 weeks vs. 5-7 weeks, p <0.05).
“Recovery time was reported to be longer for DI-ALH than for DILI (8–10 weeks vs. 5–7 weeks, p <0.05).”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [70]
Citations
Cites
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Flagged first, then by citations
Research works printed but not linked: 67
- 10.2165/00002018-200730040-00001 · DOI
- 10.3350/cmh.2012.18.3.249 · DOI
- (NIOSH) NIfOSaH, 2005, Pocket guide to chemical hazards
- 10.1111/j.1365-2036.2007.03307.x · DOI
- 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- 10.1002/hep.21095 · DOI
- 10.1016/j.mayocp.2013.09.016 · DOI · Paper page
- 10.1016/S1089-3261(02)00025-9 · DOI · Paper page
- 10.1002/hep.23588 · DOI · Paper page
- 10.1136/ard.2004.032821 · DOI
- 10.1016/j.jhep.2003.12.022 · DOI
- 10.1002/hep.23584 · DOI · Paper page
- 10.1016/0168-8278(90)90124-A · DOI · Paper page
- 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- 10.1016/S0168-8278(99)80297-9 · DOI · Paper page
- 10.1055/s-0029-1240005 · DOI
- 10.1016/0168-8278(95)80226-6 · DOI
- 10.1016/S1386-6346(02)00274-7 · DOI
- 10.1002/hep.22322 · DOI · Paper page
- 10.1111/j.1365-2125.2004.02133.x · DOI
- 10.1053/jhep.2002.34857 · DOI · Paper page
- 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- 10.1007/s12013-012-9373-y · DOI
- 10.1111/j.1365-2796.2007.01818.x · DOI
- Farrell GC, 2002, Gastrointenstinal and liver disease, 1403
- 10.1053/j.gastro.2008.09.011 · DOI · Paper page
- 10.1097/MCG.0b013e3181c5e9cc · DOI
- 10.5152/tjg.2014.4486 · DOI
- 10.1038/ajg.2010.287 · DOI · Paper page
- 10.1007/s00228-004-0888-z · DOI
- 10.1002/hep.20800 · DOI · Paper page
- 10.1002/hep.20215 · DOI
- 10.1016/j.disamonth.2013.11.002 · DOI
- 10.1016/j.cld.2007.06.003 · DOI
- 10.1007/s10654-013-9771-5 · DOI
- Xiao QH, 2004, Risk factor analysis of hepatic toxicity of antituberculosis agents, Chin J Antibiot, 29, 760
- 10.1111/j.1365-2036.2007.03355.x · DOI
- 10.1002/hep.21424 · DOI · Paper page
- Dienstag J, 2011, Harrison's principles of internal medicine
- 10.1016/j.cld.2006.05.009 · DOI
- 10.1016/j.jhep.2009.04.009 · DOI · Paper page
- 10.1007/s10620-011-1611-4 · DOI · Paper page
- 10.1345/aph.1G345 · DOI
- 10.1159/000322298 · DOI · Paper page
- 10.1038/ajg.2014.131 · DOI · Paper page
- 10.1002/hep.26709 · DOI · Paper page
- Wanless IR, 2007, Pathology of the liver, 613
- 10.1007/s00292-006-0826-1 · DOI
- Robin MA, 1997, Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug‐induced hepatitis, J Hepatol, 26, 2330
- 10.1038/nrgastro.2011.22 · DOI
- 10.1136/bmj.312.7024.169 · DOI
- 10.3109/08916938909014685 · DOI
- 10.1007/BF01316809 · DOI
- Bernard PH, 1994, Chronic active hepatitis associated with antinuclear antibodies induced by fenofibrate, Gastroenterol Clin Biol, 18, 1048
- 10.1055/s-0029-1240010 · DOI
- Kamiyama T, 1997, Autoimmune hepatitis triggered byadministration of an herbal medicine, Am J Gastroenterol, 92, 703
- Kancherla D, 2013, Metronidazole induced liver injury: a rare immune mediated drug reaction, Case Rep Gastrointest Med, 2013, 568193
- 10.1345/aph.17327 · DOI
- 10.1016/j.dld.2014.08.040 · DOI · Paper page
- 10.1002/hep.24481 · DOI · Paper page
- 10.1016/j.cld.2013.07.004 · DOI
- 10.1016/S0168-8278(02)00329-X · DOI
- 10.1111/j.1478-3231.2008.01904.x · DOI
- 10.1016/j.jhep.2011.02.024 · DOI · Paper page
- 10.1016/j.jhep.2008.10.021 · DOI · Paper page
- 10.1016/j.jhep.2010.12.041 · DOI · Paper page
- 10.1002/hep.24513 · DOI · Paper page
Cited by
Sorted by citations
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.033 · Cited by 166
Metadata
- Authors
- Kuzu, U. B., Öztaş, E., Turhan, N., Saygili, F., Suna, N., Yildiz, H., Kaplan, M., Akpinar, M. Y., Akdoğan, M., Kaçar, S., Kiliç, Z. M. Y., Köksal, A. Ş., Ödemiş, B., & Kayaçetin, E.
- Affiliations
- Departments of Gastroenterology Ankara Turkey
- Pathology Turkiye Yuksek Ihtisas Education and Research Hospital Ankara Turkey
- Venue
- Hepatology Research
- Publisher
- Wiley
- Published
- 2015-05-21
- Volume
- 46
- Issue
- 4
- Pages
- 277-291
- ISSN
- 1386-6346
- 1872-034X
- Cited by
- 12
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review